salicylic acid has been researched along with n-(4-chloro-2-fluorophenyl)-2-hydroxybenzamide in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed Ali, AA; Chang, DM; Chen, CL; Chen, TC; Huang, HS; Lee, CC; Liu, FL; Sytwu, HK | 1 |
Chiang, ML; Ho, LJ; Huang, HS; Lai, JH; Lin, CS; Liou, JT; Yang, SP | 1 |
2 other study(ies) available for salicylic acid and n-(4-chloro-2-fluorophenyl)-2-hydroxybenzamide
Article | Year |
---|---|
Modified salicylanilide and 3-phenyl-2H-benzo[e][1,3]oxazine-2,4(3H)-dione derivatives as novel inhibitors of osteoclast differentiation and bone resorption.
Topics: Animals; Bone Resorption; Cell Differentiation; Cells, Cultured; Mice; Osteoclasts; Oxazines; RANK Ligand; Salicylanilides; Structure-Activity Relationship | 2014 |
A salicylate-based small molecule HS-Cm exhibits immunomodulatory effects and inhibits dipeptidyl peptidase-IV activity in human T cells.
Topics: Benzamides; Biomarkers; Cytokines; Dipeptidyl Peptidase 4; Dipeptidyl-Peptidase IV Inhibitors; DNA; Down-Regulation; Enzyme Activation; Humans; Immunologic Factors; JNK Mitogen-Activated Protein Kinases; Lymphocyte Activation; NF-kappa B; p38 Mitogen-Activated Protein Kinases; Salicylic Acid; T-Lymphocytes; Transcription Factor AP-1 | 2014 |